RxSight
RXST

RxSight (RXST) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
StifelMaintainedHold$7.00 from $8.00Aug 10, 2026
UBSMaintainedNeutral$6.30 from $5.50Aug 6, 2026
UBSInitiated CoverageNeutral$5.50 from $9.00Jul 28, 2026
NeedhamMaintainedBuy$11.00Jul 7, 2026
B of A SecuritiesMaintainedUnderperform$6.50 from $8.00Jul 7, 2026
NeedhamMaintainedBuy$11.00 from $13.00May 7, 2026
Wells FargoMaintainedEqual-Weight$9.00 from $11.00May 7, 2026
StifelMaintainedHold$9.00 from $10.00Mar 9, 2026
NeedhamMaintainedBuy$13.00Feb 26, 2026
Piper SandlerMaintainedNeutral$10.00 from $11.00Feb 26, 2026
UBSMaintainedNeutral$9.00 from $8.00Feb 26, 2026
Piper SandlerMaintainedNeutral$11.00 from $10.00Jan 20, 2026
Morgan StanleyMaintainedEqual-Weight$10.00 from $9.00Dec 2, 2025
NeedhamMaintainedBuy$12.00 from $11.00Nov 6, 2025
Wells FargoMaintainedEqual-Weight$10.00 from $9.00Nov 6, 2025
JP MorganMaintainedUnderweight$9.00 from $8.00Nov 6, 2025
NeedhamMaintainedBuy$11.00 from $22.00Aug 8, 2025
StifelMaintainedHold$8.00 from $9.00Aug 8, 2025
UBSMaintainedNeutral$8.00 from $16.00Aug 8, 2025
Morgan StanleyDowngradedOverweight → Equal-Weight$9.00 from $20.00Jul 15, 2025

Frequently asked questions

  • What is the latest analyst rating on RXST?

    On Aug 10, 2026, Stifel maintained RxSight at Hold with a price target of $7.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.